Cytotoxicity of sophorolipid-gellan gum-gold nanoparticle conjugates and their doxorubicin loaded derivatives towards human glioma and human glioma stem cell lines

Nanoscale ◽  
2011 ◽  
Vol 3 (2) ◽  
pp. 575-580 ◽  
Author(s):  
Sheetal Dhar ◽  
E. Maheswara Reddy ◽  
Asmita Prabhune ◽  
Varsha Pokharkar ◽  
Anjali Shiras ◽  
...  
2021 ◽  
Vol 3 (Supplement_2) ◽  
pp. ii6-ii6
Author(s):  
Olivia Morris Hanon ◽  
Yamil Mahmoud ◽  
Mariana Vera ◽  
Romina Girotti ◽  
Gabriel Rabinovich ◽  
...  

Abstract Glioblastomas (GBM), the most prevalent and lethal primary brain tumors, are characterized by high intertumoral heterogeneity, diffuse infiltration, and resistance to conventional therapies. Notably, the ability of tumor cells to invade surrounding tissues is one of their most damaging characteristics, it not only causes resistance to therapies such as surgery and radiotherapy but is ultimately the primary cause of death. Therapies that cause hypoxia (e.g. anti-angiogenic therapies) have been shown to increase invasiveness, leading to resistance to the therapy itself and further complications for the patients. Using patient-derived glioma stem cell lines (GSCL) we have discovered cell lines that display heterogeneous migratory behavior in response to hypoxia. As expected we observed that four GSCLs studied had increased migration in hypoxia. Strikingly, two other cell lines studied showed decreased migration in hypoxia. This unforeseen result reflects the heterogeneous nature of GBM and the difference between these GSCLs could be key to understanding this variable. To delve into the molecular context that could explain these differences we performed an exploratory RNAseq analysis on four of the GSCLs, two that showed hypoxia-induced migration and two with decreased migration in hypoxia, and evaluated genes differentially expressed in hypoxia versus normoxia. We also carried out gene ontology and pathway enrichment analysis to discover molecular and pathway patterns consistent with the migratory behaviors observed in each group of GSCLs. The results show how that a similar migratory response to hypoxia coincides with particular sets of enriched genes and pathways. Specifically, we found NOTCH and WNT signaling pathways upregulated in GSCLs which showed increased migration in hypoxia while the IFN-gamma pathway upregulated in GSCLs with decreased migration in hypoxia. Knowing the individual molecular mechanisms responsible for the migratory behavior could allow for tailor-made therapies that reduce the dissemination of these tumors.


2009 ◽  
Vol 4 (6) ◽  
pp. 568-580 ◽  
Author(s):  
Steven M. Pollard ◽  
Koichi Yoshikawa ◽  
Ian D. Clarke ◽  
Davide Danovi ◽  
Stefan Stricker ◽  
...  

PLoS ONE ◽  
2013 ◽  
Vol 8 (2) ◽  
pp. e57462 ◽  
Author(s):  
Simona Baronchelli ◽  
Angela Bentivegna ◽  
Serena Redaelli ◽  
Gabriele Riva ◽  
Valentina Butta ◽  
...  

2015 ◽  
Vol 48 (1) ◽  
pp. 25 ◽  
Author(s):  
Maryam Rahman ◽  
Karina Reyner ◽  
Loic Deleyrolle ◽  
Sebastien Millette ◽  
Hassan Azari ◽  
...  

2013 ◽  
Vol 31 (15_suppl) ◽  
pp. 2072-2072
Author(s):  
Selby Chen ◽  
Timothy Peterson ◽  
S. Keith Anderson ◽  
Jeanette Eckel-Passow ◽  
Paul A. Decker ◽  
...  

2072 Background: Human glioma stem cells and xenograft lines are common translational models in neuro-oncology but it has not been established if they are genetically and phenotypically comparable. This study aimed to determine if human glioma xenografts and stem cell-derived tumors had similar genotypes. Methods: Matched glioma stem cell cultures and subcutaneous xenograft lines were generated from four human glioblastoma specimens (BT114, BT116, BT120, BT132). Comparison was made between subcutaneous stem cell-derived tumors (flank) and xenografts established in nude mice. Copy number variation (CNV) and gene expression microarray studies were performed. Results: Various differences in copy number and gene expression were seen. Observed CNVs included regions within EGFR, myc, and p16 (INK). For example, EGFR copy number was two fold higher in xenografts vs. stem cell-derived tumor in one line (BT114). This difference was corroborated by western blot. Other differences included a heat shock protein homolog (DNAJA4), tetraspanin 13, and a p53 family target gene (ISG20L1). Two lines (BT114, BT116) had a greater than two fold increase in DNAJA4 expression in xenografts vs. stem cell-derived tumors (p = 0.04, 0.01). Two cell lines (BT116, BT120) had a two to eight fold increase in tetraspanin 13 expression in xenografts (p = 0.02, 0.05). However, neither copy number nor gene expression variations were consistent across all cell lines. Conclusions: Xenografts and glioma stem cell-derived tumors established from the same patient specimens have distinct genotypes. Further work is needed to establish if these differences are random or represent characteristic changes selected by different in vitro or in vivo pressures. However, these variations raise questions regarding which model is ideal for studying glioma biology, and which ones best replicate glioma characteristics in human patients.


2016 ◽  
Vol 18 (suppl_6) ◽  
pp. vi183-vi183
Author(s):  
Akio Soeda ◽  
Deric Park ◽  
Toru Iwama

Sign in / Sign up

Export Citation Format

Share Document